Bacterial Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type, By Patient Age Group, By Distribution Channel, By Route of Administration, By Region & Competition, 2020-2030F
상품코드:1691700
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세균 백신 세계 시장은 2024년에 71억 달러로 평가되었으며, 2030년까지 CAGR은 7.20%를 나타낼 전망입니다.
세균 면역 또는 세균 백신으로도 알려진 세균 백신은 신체의 면역계를 자극하여 특정 세균 병원체를 인식하고 싸우도록 설계된 예방 의학의 한 유형입니다. 이 백신은 세균 성분과 불활성화된 세균 세포를 사용하여 만들어지며 다양한 세균 감염에 대한 면역성을 제공합니다. 세균 백신은 심각한 질병과 합병증을 일으키고 심지어 죽음에 이르기까지 다양한 세균 감염을 예방하는 데 매우 중요합니다. 백신에 의해 예방되는 일반적인 세균 질환에는 파상풍, 디프테리아, 백일해, 폐렴, 수막염 등이 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
71억 달러
시장 규모 : 2030년
106억 9,000만 달러
CAGR : 2025-2030년
7.20%
급성장 부문
주사용 백신
최대 시장
북미
세균 백신에 의한 백신 접종의 보급은 접종자를 보호할 뿐만 아니라 집단 면역에도 기여합니다. 이것은 특정 건강 상태에 있는 사람이나 면역력이 저하된 사람 등 의료상의 이유로 백신을 접종할 수 없는 사람을 간접적으로 지키게 됩니다. 세균 백신은 특히 저소득 및 중산층 국가에서 세계 건강 활동에 중요한 역할을 하고 있습니다. 예방 접종 프로그램은 세균성 질환의 부담을 줄이고 아이의 생존율을 높이고 전체 공중 보건을 향상시킵니다. 예를 들어, 2025년 미국 질병 예방관리센터(CDC)에 따르면 집단 감염으로 75,968명의 사례가 보고되었으며, 4,235명이 사망했으며, 이는 전염병 확산의 중요한 영향을 강조합니다.
Global Bacterial Vaccines Market was valued at USD 7.10 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 7.20% through 2030. Bacterial vaccines, also known as bacterial immunizations or bacterial vaccines, are a type of preventive medicine designed to stimulate the body's immune system to recognize and fight against specific bacterial pathogens. These vaccines are created using components of bacteria or inactivated bacterial cells to provide immunity against various bacterial infections. Bacterial vaccines are crucial for preventing a wide range of bacterial infections that can cause serious illnesses, complications, and even death. Common bacterial diseases prevented by vaccines include tetanus, diphtheria, pertussis, pneumonia, and meningitis.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 7.10 Billion
Market Size 2030
USD 10.69 Billion
CAGR 2025-2030
7.20%
Fastest Growing Segment
Injectable Vaccines
Largest Market
North America
Widespread vaccination with bacterial vaccines not only protects vaccinated individuals but also contributes to herd immunity. This indirectly protects those who cannot receive vaccines due to medical reasons, such as individuals with certain health conditions or weakened immune systems. Bacterial vaccines play a critical role in global health efforts, especially in low- and middle-income countries. Vaccination programs reduce the burden of bacterial diseases, improve child survival rates, and enhance overall public health. For instance, according to the Centers for Disease Control and Prevention (CDC) in 2025, outbreaks resulted in 75,968 reported human cases and 4,235 deaths, highlighting the significant impact of infectious disease spread.
Key Market Drivers
Emerging Infectious Diseases
Emerging Infectious Diseases (EIDs) are diseases that have recently appeared in a population or have existed but are rapidly increasing in incidence or geographic range. These diseases often pose a significant threat to public health because they are novel, poorly understood, and may lack effective treatments. Bacterial EIDs can include diseases caused by antibiotic-resistant strains or previously unrecognized pathogens. Bacterial vaccines are crucial tools for the prevention and control of emerging bacterial infections. They provide a proactive approach to combat new threats by preparing populations with immunity against specific bacterial pathogens. In the event of an outbreak of an emerging bacterial infection, rapid vaccination campaigns can be implemented to contain the spread of the disease. This is particularly important in preventing large-scale epidemics or pandemics. For instance, according to WHO 2024, better vaccine use could cut antibiotic use by 2.5 billion doses annually, preventing deaths from antimicrobial resistance, reducing treatment costs, and curbing the spread of resistant infections.
Key Market Challenges
Vaccine Hesitancy
Vaccine hesitancy refers to the reluctance or refusal of individuals or communities to accept vaccines, despite the availability of vaccination services. This hesitancy can manifest for various reasons, including safety concerns, misinformation, and distrust of vaccines and healthcare systems. Vaccine hesitancy can lead to lower vaccination rates, which means that fewer individuals are protected against bacterial infections. This can result in pockets of susceptible individuals within a community, increasing the risk of disease outbreaks. Lower vaccine coverage due to hesitancy reduces the level of herd immunity within a population. This not only puts unvaccinated individuals at risk but also makes it easier for bacterial diseases to spread within the community. Vaccine hesitancy can impede public health efforts to control bacterial infections. Diseases that were once well-controlled can experience resurgence when vaccine coverage declines. A rise in vaccine-preventable diseases due to hesitancy can strain healthcare systems, leading to increased healthcare costs associated with treating these diseases and their complications. Governments and healthcare organizations must allocate resources to combat vaccine hesitancy through public health campaigns, educational initiatives, and outreach efforts. These resources could be used elsewhere if hesitancy was not a factor. Reduced demand for bacterial vaccines may affect funding for research and development of new vaccines and improvements to existing ones. Pharmaceutical companies may be less motivated to invest in vaccine development if there is lower demand. The spread of misinformation and vaccine-related myths on social media platforms can contribute to vaccine hesitancy. False information can erode public trust in vaccines and healthcare providers. Safety concerns, whether founded in evidence or not, can lead to hesitancy. High-profile vaccine safety scares can have lasting effects on public perception.
Key Market Trends
Pipeline Developments
Pharmaceutical companies and research institutions are actively working on expanding their portfolio of bacterial vaccines. This includes developing vaccines for a wide range of bacterial pathogens responsible for various infectious diseases. The emergence of new bacterial pathogens or the reemergence of existing ones often prompts the development of vaccines to address these threats. Recent examples include vaccine development efforts in response to antibiotic-resistant strains of bacteria. Advances in vaccine technology, including the use of novel adjuvants, recombinant DNA technology, and conjugate vaccine platforms, are driving innovation in bacterial vaccine development. These technologies can improve vaccine efficacy and safety. Research is focused on developing highly targeted vaccines that are effective against specific bacterial strains or serotypes. Precision in vaccine design is important for combating antibiotic-resistant bacteria. Some pipeline developments involve multivalent vaccines that target multiple bacterial strains or serotypes in a single vaccine formulation. This can simplify vaccination schedules and improve coverage. International organizations and governments are supporting vaccine research and development for bacterial diseases that disproportionately affect low- and middle-income countries. These initiatives are aimed at reducing global health disparities. Recent pandemics, such as COVID-19, have highlighted the importance of vaccine development for emerging infectious diseases, including those caused by bacterial pathogens. Preparedness efforts include research into rapid vaccine development platforms.
Key Market Players
Pfizer Inc.
GSK plc
Novartis AG
Mylan N.V.
Sanofi SA
Boehringer Ingelheim International GmbH.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Bharat Biotech International Ltd
Serum Institute of India Pvt. Ltd
Report Scope:
In this report, the Global Bacterial Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Bacterial Vaccines Market, By Vaccine Type:
Pertussis (Whooping Cough) Vaccines
Tetanus Vaccines
Diphtheria Vaccines
Pneumococcal Vaccines
Meningococcal Vaccines
Typhoid Vaccines
Tuberculosis (TB) Vaccines
Cholera Vaccines
Shigellosis Vaccines
Others
Bacterial Vaccines Market, By Patient Age Group:
Pediatric Vaccines (Infants, Children)
Adolescent Vaccines
Adult Vaccines
Geriatric Vaccines
Bacterial Vaccines Market, By Distribution Channel:
Government Agencies and Programs
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
Others
Bacterial Vaccines Market, By Route of Administration:
Injectable Vaccines
Oral Vaccines
Nasal Vaccines
Bacterial Vaccines Market, By region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Bacterial Vaccines Market.
Available Customizations:
Global Bacterial Vaccines Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
